Back to CGEM
NORTHERN TRUST CORP CGEM Position History
Cullinan Therapeutics, Inc. • Healthcare
Quarters held
20
Latest value
$73K
Q3 2026
Peak value
$9.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $84K |
| Q4 2025 | $128K |
| Q4 2025 | $55K |
| Q4 2025 | $4.1M |
| Q4 2025 | $34K |
| Q1 2026 | $107K |
| Q1 2026 | $176K |
| Q1 2026 | $76K |
| Q1 2026 | $6M |
| Q1 2026 | $59K |
| Q2 2026 | $173K |
| Q2 2026 | $225K |
| Q2 2026 | $97K |
| Q2 2026 | $9.8M |
| Q2 2026 | $85K |
| Q3 2026 | $137K |
| Q3 2026 | $190K |
| Q3 2026 | $82K |
| Q3 2026 | $8.1M |
| Q3 2026 | $73K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $73K | 4.7K | — | — |
| Q3 2026 | $8.1M | 526.8K | — | — |
| Q3 2026 | $82K | 5.4K | — | — |
| Q3 2026 | $190K | 12.4K | — | — |
| Q3 2026 | $137K | 8.9K | — | — |
| Q2 2026 | $85K | 4.6K | — | — |
| Q2 2026 | $9.8M | 539.2K | — | — |
| Q2 2026 | $97K | 5.4K | — | — |
| Q2 2026 | $225K | 12.4K | — | — |
| Q2 2026 | $173K | 9.5K | — | — |
| Q1 2026 | $59K | 4.2K | — | — |
| Q1 2026 | $6M | 419.8K | — | — |
| Q1 2026 | $76K | 5.4K | — | — |
| Q1 2026 | $176K | 12.4K | — | — |
| Q1 2026 | $107K | 7.5K | — | — |
| Q4 2025 | $34K | 3.3K | — | — |
| Q4 2025 | $4.1M | 392.5K | — | — |
| Q4 2025 | $55K | 5.4K | — | — |
| Q4 2025 | $128K | 12.4K | — | — |
| Q4 2025 | $84K | 8.1K | — | — |
Other funds holding CGEM
$177.2M
$163.2M
$163.2M
$149.2M
$137.6M
$127.4M
$108.7M
$104.7M